文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

2018年HIV-TRePS系统更新:开发新计算模型预测HIV治疗结局(有无基因型均可),并增强低收入环境下的可用性

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

本研究开发并验证了用于预测HIV病毒学应答的随机森林计算模型,训练数据最多包括50000例无基因型治疗更换事件和18000例有基因型事件。无基因型模型AUC为0.82和0.81,有基因型模型AUC为0.86和0.84,均显著优于基于规则解释的基因型检测(AUC仅0.55-0.63),能识别临床失败方案的替代有效方案。

要点

  • 无基因型模型AUC 0.82(标准窗口)和0.81(放宽窗口),有基因型模型AUC 0.86(新非依从性过滤器)和0.84(无过滤器)。
  • 基于规则解释的基因型检测AUC仅0.55-0.63,模型预测准确性显著更高。
  • 模型可为临床失败方案识别预测有效的替代方案,尤其适用于资源有限环境。

核心结论

  • 最新全球模型即使无基因型也能准确预测治疗应答,有潜力帮助优化治疗,尤其在资源有限环境。

研究设计与样本

  • 随机森林模型训练用于预测病毒学失败后新治疗的病毒学应答概率,使用最多50000例无基因型治疗更换事件和18000例有基因型事件。
  • 使用独立数据集评估模型,测试放宽基线数据时间窗、使用新过滤器排除可能非依从病例以及添加马拉维若、替拉那韦和埃替拉韦对模型准确性的影响。

主要发现

  • 无基因型模型使用标准和放宽基线数据窗口的AUC分别为0.82和0.81。
  • 有基因型模型使用新非依从性过滤器的AUC为0.86,无过滤器为0.84。
  • 基于规则解释的基因型检测AUC仅0.55-0.63,模型显著更准确,并略优于先前模型。
  • 模型能为临床新方案失败的绝大多数病例识别预测有效的替代方案。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Optimizing antiretroviral drug combination on an individual basis can be challenging, particularly in settings with limited access to drugs and genotypic resistance testing. Here we describe our latest computational models to predict treatment responses, with or without a genotype, and compare their predictive accuracy with that of genotyping. METHODS: Random forest models were trained to predict the probability of virological response to a new therapy introduced following virological failure using up to 50 000 treatment change episodes (TCEs) without a genotype and 18 000 TCEs including genotypes. Independent data sets were used to evaluate the models. This study tested the effects on model accuracy of relaxing the baseline data timing windows, the use of a new filter to exclude probable non-adherent cases and the addition of maraviroc, tipranavir and elvitegravir to the system. RESULTS: The no-genotype models achieved area under the receiver operator characteristic curve (AUC) values of 0.82 and 0.81 using the standard and relaxed baseline data windows, respectively. The genotype models achieved AUC values of 0.86 with the new non-adherence filter and 0.84 without. Both sets of models were significantly more accurate than genotyping with rules-based interpretation, which achieved AUC values of only 0.55-0.63, and were marginally more accurate than previous models. The models were able to identify alternative regimens that were predicted to be effective for the vast majority of cases in which the new regimen prescribed in the clinic failed. CONCLUSIONS: These latest global models predict treatment responses accurately even without a genotype and have the potential to help optimize therapy, particularly in resource-limited settings.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Revell AD, Wang D, Perez-Elias MJ, et al. 2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. J Antimicrob Chemother. 2018. PMID: 29889249. doi:10.1093/jac/dky179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。